Sapna M. is a business-oriented IP leader with extensive experience in IP strategy, global patent portfolio management, and IP due diligence within the life sciences sector. They served as Senior Corporate Patent Counsel at MilliporeSigma from 2007 to 2017 and held various prominent roles at organizations like Takeda and Editas Medicine. Currently, they are the Head of IP at Abcam, while also leading IP and Legal Affairs at Sonata Therapeutics. Sapna M. has a proven track record in cell and gene therapy, mRNA therapeutics, and other cutting-edge biotechnologies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices